Pall Medical

Pall Medical
Share

Pall Medical

 •  October 14, 2016

Pall Life Sciences, a division of global filtration, separation and purification leader Pall Corporation, is pleased to announce the launch of the Kleenpak® Presto sterile connector to be used in a wide range of applications in upstream, downstream, and formulation and filling.
“We launched the Presto genderless sterile connector family in direct...

Pall Medical

 •  October 5, 2016

Pall Corporation, a global leader in bioprocess equipment and disposables, announced the signing of a commercial collaboration agreement with RoosterBio Inc., an innovative adult stem cell technology company. The agreement will encompass a co-development and marketing partnership, delivering complete solutions for industrial-scale bioreactor...

Pall Medical

 •  September 28, 2016

PORT WASHINGTON, N.Y., September 28, 2016 - At next week’s first annual Biotech Week Boston (October 4-7, 2016), Pall Corporation, a global leader in filtration, separation and purification, will officially launch new production-scale technologies and preview upcoming technologies that enable fully continuous biopharmaceutical processing using...

Pall Medical

 •  April 26, 2016

Pall Life Sciences Biopharmaceutical division of global filtration, separation, and purification leader Pall Corporation, is pleased to announce the commercial launch of the CadenceTM Acoustic Separator (CAS), which applies acoustic wave separation technology in a novel single-use format for the clarification of cell culture bioprocess fluids. The...

Pall Medical

 •  July 13, 2015

Pall Corporation (NYSE:PLL) today announced the availability of its new 10 nm XpressKleen™ filter. The filter is the latest addition to Pall’s successful XpressKleen chemical filter line-up and is a key component of Pall’s disposable PFA KleenChange® assemblies. The new filter will be featured at SEMICON West in San Francisco.

The new 10 nm ...

Pall Medical

 •  June 16, 2015

Pall Corporation (NYSE:PLL) today announced that it has set the record date for the special meeting of its shareholders to, among other things, consider and vote on a proposal to adopt the previously announced Agreement and Plan of Merger, dated May 12, 2015 (the “Merger Agreement”), by and among Pall, Danaher Corporation (NYSE:DHR), a Delaware ...

Pall Medical

 •  May 21, 2015

Sales in the quarter were flat; up 11% in local currencyDiluted EPS in the quarter of $0.89 up 11%; pro forma diluted EPS of $0.92, up 14%Free cash flow in the nine months of $321 million, up 10%Third Quarter and Nine Months Sales and Earnings OverviewThird quarter sales were $681.1 million compared to $682.4 million last year. Sales in local ...

Pall Medical

 •  April 15, 2015

PORT WASHINGTON, N.Y., April 15, 2015 - First paragraph, second sentence of release should read: The dividend is payable on May 8, 2015 to shareholders of record on the close of business on April 25, 2015 (instead of: The dividend is payable on May 8, 2015 to shareholders of record on the close of business on April 24, 2015).The corrected release ...

Pall Medical

 •  February 4, 2015

PORT WASHINGTON, N.Y., February 04, 2015 - Pall Corporation (NYSE:PLL) -- will report second quarter fiscal year 2015 financial results on Tuesday, February 24, 2015 at 7:00 a.m. ET.A conference call to review the company's results will be broadcast live over the Internet the same day at 8:30 a.m. ET on Tuesday, February 24, 2015.A live and ...

Pall Medical

 •  January 28, 2015

PORT WASHINGTON, N.Y., January 28, 2015 - Pall Corporation (NYSE:PLL) today announced that its board of directors declared a quarterly dividend of $0.305 per share. The dividend is payable on February 20, 2015 to shareholders of record on the close of business on February 9, 2015.About Pall CorporationPall Corporation (NYSE:PLL) is a filtration, ...